FR2317918A1 - Amino acid solns. for parenteral nutrition of infants - contg. balanced amts. of essential amino acids - Google Patents

Amino acid solns. for parenteral nutrition of infants - contg. balanced amts. of essential amino acids

Info

Publication number
FR2317918A1
FR2317918A1 FR7620327A FR7620327A FR2317918A1 FR 2317918 A1 FR2317918 A1 FR 2317918A1 FR 7620327 A FR7620327 A FR 7620327A FR 7620327 A FR7620327 A FR 7620327A FR 2317918 A1 FR2317918 A1 FR 2317918A1
Authority
FR
France
Prior art keywords
amino acid
amts
balanced
essential amino
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7620327A
Other languages
French (fr)
Other versions
FR2317918B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Eduard Fresenius Chemisch Pharmazeutische Industrie KG
Original Assignee
Dr Eduard Fresenius Chemisch Pharmazeutische Industrie KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Eduard Fresenius Chemisch Pharmazeutische Industrie KG filed Critical Dr Eduard Fresenius Chemisch Pharmazeutische Industrie KG
Publication of FR2317918A1 publication Critical patent/FR2317918A1/en
Application granted granted Critical
Publication of FR2317918B1 publication Critical patent/FR2317918B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The new soln. contain essential amino acid nitrogen in the following amts. per 16g total nitrogen: L-isoleucine N 700-800 mg; L-leucine N1200-1300 mg; L-lysine N 1400-1600 mg; L-methionine and L-cysteine N 490-560 mg; L-phenylalanine N400-460 mg; L-threonine N 600-700 mg; L-tryptophan N240-310 mg and L-valine N 900-980 mg. The relative amounts of the essential amino acids are so balanced as to give good incorporation of the nitrogen into the infant organism without giving rise to disorders of amino acid metabolism shown by imbalances in serum amino acid levels. Pref. solutions contain (per 16g total N) 745-770 mg-L-isoleucine N; 1240-1290 mg L-leucine N; 1450-1550mg L-lysine N; 520-550mg L-methionine and L-cysteine N; 410-450mg L-threonine N; 260-290 mg L-tryptophan N; and 910-960 mg L-valine N.
FR7620327A 1975-07-12 1976-07-02 Amino acid solns. for parenteral nutrition of infants - contg. balanced amts. of essential amino acids Granted FR2317918A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752531201 DE2531201C2 (en) 1975-07-12 1975-07-12 Amino acid infusion solutions for use in premature babies to young children

Publications (2)

Publication Number Publication Date
FR2317918A1 true FR2317918A1 (en) 1977-02-11
FR2317918B1 FR2317918B1 (en) 1979-05-18

Family

ID=5951354

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7620327A Granted FR2317918A1 (en) 1975-07-12 1976-07-02 Amino acid solns. for parenteral nutrition of infants - contg. balanced amts. of essential amino acids

Country Status (2)

Country Link
DE (1) DE2531201C2 (en)
FR (1) FR2317918A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2365552A1 (en) * 1976-09-23 1978-04-21 Fresenius Chem Pharm Ind L-amino acids mixt. for treatment of liver insufficiency - contg. (iso)leucine, lysine, methionine, cysteine, phenylalanine, tyrosine, threonine, tryptophan and valine in the form of protein(s)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3821043A1 (en) * 1988-06-22 1989-12-28 Fresenius Ag DIALYZER AND SPUEL SOLUTION FOR INTRAPERITONEAL ADMINISTRATION

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2260189A1 (en) * 1971-12-09 1973-06-20 Hossein Ghadimi INJECTABLE AMINO ACID PREPARATIONS
FR2215212A1 (en) * 1973-01-18 1974-08-23 Seperic

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2260189A1 (en) * 1971-12-09 1973-06-20 Hossein Ghadimi INJECTABLE AMINO ACID PREPARATIONS
FR2215212A1 (en) * 1973-01-18 1974-08-23 Seperic

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2365552A1 (en) * 1976-09-23 1978-04-21 Fresenius Chem Pharm Ind L-amino acids mixt. for treatment of liver insufficiency - contg. (iso)leucine, lysine, methionine, cysteine, phenylalanine, tyrosine, threonine, tryptophan and valine in the form of protein(s)

Also Published As

Publication number Publication date
DE2531201C2 (en) 1986-05-28
FR2317918B1 (en) 1979-05-18
DE2531201A1 (en) 1977-01-20

Similar Documents

Publication Publication Date Title
GB1507951A (en) Amino acid formulations
Pohlandt Cystine: a semi‐essential amino acid in the newborn infant
Collier et al. Nonidentity of the aspartate and the aromatic aminotransferase components of transaminase A in Escherichia coli
ZA849312B (en) Dietetic supplement and prepackaged food in which it is contained.process of preparation and method of administration
Soda et al. L-lysine-. alpha.-ketoglutarate aminotransferase. II. Purification, crystallization, and properties
Cho et al. A study on flavorous taste components in kimchis-on free amino acids
Mauron et al. Reciprocal induction and repression of serine dehydratase and phosphoglycerate dehydrogenase by proteins and dietary‐essential amino acids in rat liver
UEDA et al. Intestinal absorption of amino acids IV. Participation of pyridoxal phosphate in the active transfer of L-amino acids through the intestinal wall
SE7909497L (en) amino acid salt
Pascal et al. Cystathionase: immunochemical evidence for absence from human fetal liver
FR2317918A1 (en) Amino acid solns. for parenteral nutrition of infants - contg. balanced amts. of essential amino acids
Lyons et al. The regulation of ornithine aminotransferase synthesis by glucagon in the rat
Yonaha et al. γ-Aminobutyrate: α-ketoglutarate aminotransferase from Pseudomonas sp. F-126: purification, crystallization, and enzymologic properties
Oka et al. On the specificity of a rennin-like enzyme from Mucor pusillus
El-Sayed et al. Biochemical and pharmacokinetic properties of PEGylated cystathionine γ-lyase from Aspergillus carneus KF723837
FR2317917A1 (en) Oral and parenteral amino acid solutions - contg. essential and nonessential l-amino acids in specified proportions
Krista et al. Beef brain cytoplasmic aspartate aminotransferase. Purification, kinetics, and physical properties
FR2316933A1 (en) Amino acid mixts. for treating kidney and liver disorders - with reduced methionine and phenylalanine content
LAIN‐GUELBENZU et al. Purification and properties of L‐alanine aminotransferase from Chlamydomonas reinhardtii
GB1460108A (en) Pharmaceutical preparations containing aspirin or indomethacin
FR2317919A1 (en) Amino acid mixts. contg. hydroxy or keto analogues - for treating kidney and liver disorders
Tarver Metabolism of amino acids and proteins
Tsuda et al. Effect of dietary proteins on the turnover of rat liver argininosuccinate synthetase
Yoshida et al. Purification, crystallization and properties of tryptophanase from Proteus rettgeri
GB1496254A (en) Nutritive infusion solution and its production